Mankind Pharma Ltd

NSE: MANKIND · BSE: 543904 · Pharmaceuticals & Biotechnology · 50 announcements

Share price: ₹2,500.00
Market cap: ₹1,03,261 Cr
Revenue (annual): ₹14,278 Cr
Net profit (annual): ₹1,913 Cr
P/E (TTM): 50.5×Sector 47.3×
Promoter holding: 72.63%-0.03% QoQ
FII holding: 9.45%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Merger & Restructuring 8 Annual General Meeting 4 Other Announcement 3 Management Change 2 Employee Stock Options 2 Earnings Call 2 Share Pledge 1 Results Update 1 Partnership 1 Financial Results 1 Debt & Borrowing 1 Business Update 1 Board Meeting Date 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

30 Jul 2026 16:07 IST BSE

Debt & Borrowing

Mankind Pharma Debt & Borrowing: ₹150 Cr

Mankind Pharma approved a ₹150 Crore corporate guarantee in favour of banks for Bharat Serums and Vaccines Limited's credit facilities. This contingent liability supports BSV's operations.

Value: ₹150.0 Cr

Read the filing ↗